Asset Management

  • July 28, 2026

    Simpson Thacher Stock Work Hurt 2 Companies, Jury Told

    The chief financial officer for an insurance company told a Florida jury Tuesday that a stock drop for Patriot National Inc. — which is suing Simpson Thacher & Bartlett LLP for malpractice for allegedly putting together a shoddy securities offering — dramatically affected his own business as well.

  • July 28, 2026

    Insurance Co. Beats Kosovo Citizens' Disability Benefits Suit

    A New York Life Insurance Co. unit defeated a lawsuit alleging it breached Pennsylvania law when it denied disability benefits to 17 Kosovo citizens who supported the U.S. military in Afghanistan, with a federal judge ruling the claims are preempted by the Employee Retirement Income Security Act.

  • July 28, 2026

    Watchdog Org. Asks Court For Trump-IRS Deal Docs

    A watchdog organization asked a D.C. federal court to order the government to disclose communications relating to the settlement between President Donald Trump and the Internal Revenue Service over leaks of his tax information.

  • July 28, 2026

    Political Org. Wins $5.2M In Benefits Bequeathed By NYU Prof

    A New York federal judge awarded $5.2 million in retirement benefits from a late New York University sociology professor to the Democratic Socialists of America, rejecting arguments from the professor's nephew that the organization didn't have a right to the cash.

  • July 28, 2026

    Trader In BigLaw Deal-Tipping Scheme To Plead Guilty

    A Florida resident is set to plead guilty to his alleged role in a sweeping scheme to trade on insider information about impending acquisitions that was stolen from major law firms, according to a court filing Tuesday.

  • July 27, 2026

    NY AG Says States Must Have Power To Police Crypto, Ethics

    New York Attorney General Letitia James called on federal lawmakers Monday to amend a pending proposal to regulate crypto markets to give states more latitude to protect consumers, go after scammers and hold government officials like the president accountable for profiting from the industry.

  • July 27, 2026

    SEC Fines Simplify $400K Over ETF Transaction Violations

    A Delaware-based registered investment adviser has agreed to pay a $400,000 fine to the U.S. Securities and Exchange Commission to resolve claims that, among other things, it caused an affiliated trust to engage in prohibited transactions and separately caused one of its exchange-traded funds to exceed leverage thresholds for derivatives trading.

  • July 27, 2026

    ATI Beats ERISA Suit Over $1.5B Pension Risk Transfer

    Defense and aerospace company ATI won escape from a proposed class action alleging it put retirees' benefits at risk by transferring approximately $1.5 billion of pension obligations to a private equity-backed insurance company, convincing a Pennsylvania federal court Monday that ex-workers hadn't sufficiently demonstrated standing to sue.

  • July 27, 2026

    Del. Judge Tosses Challenge To Envestnet's $4.5B Bain Sale

    The Delaware Chancery Court has dismissed a stockholder challenge to Envestnet Inc.'s $4.5 billion take-private sale to Bain Capital affiliates, ruling that investors approved the deal through a fully informed vote and that the complaint failed to support claims that the company's independent directors or financial adviser Morgan Stanley acted improperly.

  • July 27, 2026

    PE Shop Founder Pleads Guilty In $50M Ponzi Scheme

    The managing partner of a New Hampshire-based private equity firm has pled guilty in New York federal court to multiple counts of fraud and money laundering in connection with a scheme that solicited over $50 million in investments for purported health and wellness companies.

  • July 27, 2026

    Yale, Biohaven Win $4M In Biotech Trade Secret Trial

    A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.

  • July 27, 2026

    Simpson Thacher Atty Says Patriot Nat'l Founder Sank Co.

    A Simpson Thacher & Bartlett LLP partner wrapped up her testimony Monday in a Florida state malpractice trial brought by the founder of Patriot National Inc., telling the jury that the founder was willing to forgo establishing a floor on the value of so-called Series B warrants, which he says contributed to the company's demise.

  • July 27, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week tackled disputes involving restrictive covenants, corporate governance, trade secrets, real estate investments, receiverships, and books and records demands.

  • July 27, 2026

    Antares Raises $470M For Military Nuclear Reactor Push

    U.S. Department of Energy Reactor Pilot Program participant Antares announced Monday that it had raised $470 million in its Series C funding, which will allow the company to accelerate the commercialization of its nuclear power systems.

  • July 27, 2026

    TransDigm To Buy Aerospace Manufacturer In $1.1B Deal

    Aircraft company TransDigm, advised by BakerHostetler, unveiled plans Monday to acquire manufacturing company Prince & Izant from Paul Hastings LLP-led Industrial Growth Partners in a roughly $1.1 billion cash deal.

  • July 27, 2026

    Investment Bank Says Workers' Wage Suit Is Contract Dispute

    An investment bank and two managing directors are urging a Texas federal judge to toss a proposed collective action alleging employees went months without pay, arguing that the workers were exempt from overtime and had turned a contract dispute into a federal wage law case.

  • July 24, 2026

    Ex-DLA Piper Tax Partner Rejoins Gibson Dunn

    Former DLA Piper partner James Manzione has returned to Gibson Dunn & Crutcher LLP as a tax partner in its New York City office.

  • July 24, 2026

    2 Conservative Airbnb Investors Drop Proxy Bias Suit

    Two right-leaning institutional investors that accused Airbnb of wrongly excluding their shareholder proposals from proxy materials have been allowed to quietly drop their lawsuit against the short-term rental business.

  • July 24, 2026

    FINRA Report Signals Quicker, Clearer Enforcement Ahead

    The Financial Industry Regulatory Authority appears to be open to recent outside recommendations to update the enforcement process at the broker-dealer regulator, and experts tell Law360 the changes could offer firms more transparency, more opportunities for proactive defense and easier ways to receive cooperation credit.

  • July 24, 2026

    Traders Say Louis Dreyfus Can't Decert, Arbitrate Cotton Suit

    Cotton futures traders want a New York federal judge to keep their certified class action moving toward trial, arguing that Louis Dreyfus Commodities BV has no basis to force some class members into arbitration or to disqualify the named plaintiff and undo certification.

  • July 24, 2026

    Amundsen Davis Sued For Malpractice Over Nobu Hotel Case

    Amundsen Davis is facing a lawsuit in Illinois federal court from the romantic partner of a construction executive convicted of misusing millions intended for Chicago's Nobu Hotel, alleging the firm failed to notify her of a roughly $750,000 turnover judgment entered against her personally before the window to appeal expired.

  • July 24, 2026

    Cornerstone, Old Republic Partly Settle $9.8M Coverage Suit

    A building products manufacturer has settled its coverage dispute with Old Republic Insurance Co., though its claims against Berkshire Hathaway Specialty Insurance Co., seeking $9.8 million in coverage for defense and settlement costs in other litigation, remain unresolved.

  • July 24, 2026

    Fenwick, Latham Lead Scribe Therapeutics' $129M IPO

    Early-stage biotechnology firm Scribe Therapeutics began trading publicly on Friday after raising $129 million in its upsized initial public offering steered by Fenwick & West LLP and Latham & Watkins LLP.

  • July 24, 2026

    Surgery Partners Stake Sale Values Idaho Hospitals At $1.2B

    Surgery Partners, an owner and operator of short-stay surgical facilities, said Friday it has reached a deal to sell its stake in two Idaho hospitals for nearly $800 million to Salt Lake City, Utah-based Intermountain Health.

  • July 24, 2026

    Taxation With Representation: Kleinberg Kaplan, Baker Botts

    In this week's Taxation With Representation, Brookfield Asset Management acquires Aypa Power from funds managed by Blackstone Energy Transition Partners, Brookfield and Canada Pension Plan Investment Board buy LXP Industrial Trust, and Novagold Resources Inc. and Paulson Advisers LLC agree to give Novagold full ownership of Donlin Gold LLC.

Expert Analysis

  • The Debanking Minefield: Navigating Fair Access In 2026

    Author Photo

    Federal regulators' recent elimination of reputational risk from bank supervision, alongside a growing patchwork of state fair access laws, is reshaping how banks make account and service decisions and ushering in a new compliance era requiring individualized, objective and risk-based access determinations, say attorneys at Spencer Fane.

  • Assessing New Risks After The End Of The SEC's Gag Rule

    Author Photo

    The U.S. Securities and Exchange Commission's recent rescission of its long-standing no‑deny gag rule marks a transition from a regime of enforced silence to one of strategic communication, meaning the question is no longer simply whether to settle, but how to manage the narrative that follows, say attorneys at Nelson Mullins.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • Opinion

    Shareholder Derivative Litigation Needs A Better Framework

    Author Photo

    Uncoordinated, multiforum shareholder derivative litigation is a growing issue for corporate defendants that have little to no recourse for organizing and consolidating actions, but several commonsense steps should be utilized to preempt such disputes, say attorneys at Sullivan & Cromwell.

  • How State, Local Rules Are Expanding Debt Collection Reach

    Author Photo

    Consumer protection rules recently enacted by several states signal that the rules of debt collection are being rewritten at a pace that should command the attention of every creditor, servicer, debt buyer, collection agency and collection law firm operating across state lines, says Weldianne Scales at Reed Smith.

  • How Nixing Trade-Through Rule Would Alter Equity Markets

    Author Photo

    The U.S. Securities and Exchange Commission's recent proposal to rescind the trade-through rule and the locked-and-crossed-markets prohibition represents one of the most significant potential changes to U.S. equity market structure in two decades, affecting exchanges, broker-dealers, and institutional and retail investors alike, say attorneys at WilmerHale.

  • The Nuance Between The Atkins, Gensler SEC Strategic Plans

    Author Photo

    U.S. Securities and Exchange Commission Chairman Paul Atkins' recent draft strategic plan is a marked departure from that of former Chair Gary Gensler, portraying an intention to leave decisions to the market rather than steering corporate behavior through expansive disclosure mandates and regulatory enforcement, say attorneys at Cleary.

  • Future Of Fed Independence Shaky After Justices' Ruling

    Author Photo

    The U.S. Supreme Court's recent ruling in Trump v. Cook preserved the Federal Reserve's formal independence but could invite the president to remove board members with just modest protections, leaving the central bank's autonomy uncertain and potentially setting up fresh clashes over other agencies, says Steven Schwinn at the University of Chicago.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • How Rated Note Feeders Help Insurers Tap Private Credit

    Author Photo

    With insurer investments comprising nearly a third of the private credit market, rated note feeders offer insurers a compelling way to access private credit yields through debt instruments by balancing key features of debt investment with the structural and economic profiles of private credit funds, say attorneys at Akin.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Agentic AI And Securities Law: Who Is The Adviser?

    Author Photo

    Securities regulation has always been actor-based, but as agentic artificial intelligence becomes more common, it will push the law toward a partially system-based framework in which systems themselves, and the relationships between them and their deployers, are the focus of regulatory attention, says Joseph A. Hall at Davis Polk.

  • Have Private Suits Filled Gap Left By SEC's Crypto Pullback?

    Author Photo

    In the wake of the U.S. Securities and Exchange Commission's regulatory retreat in the crypto space, private litigants have pursued claims across different types of crypto-related activities and market participants, but whether private lawsuits have replaced SEC enforcement remains unclear, says Simona Mola at NERA.

  • A Potential Turning Point For Short-And-Distort Claims

    Author Photo

    A California federal jury's conviction of Andrew Left signals that the historically blurry line between securities fraud and legitimate criticism of companies is growing clearer, and that there is a viable recourse against so-called short-and-distort campaigns intended to create a false impression of the market, say attorneys at Baker McKenzie.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Asset Management archive.